Cutler Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-700
Closed -$2K 4300
2023
Q1
$2K Sell
700
-900
-56% -$216K ﹤0.01% 3281
2022
Q4
$16K Buy
+1,600
New +$293K ﹤0.01% 2410
2022
Q3
Sell
-100
Closed -$1K 5650
2022
Q2
$1K Hold
100
﹤0.01% 4791
2022
Q1
$1K Hold
100
﹤0.01% 5133
2021
Q4
$1K Buy
+100
New +$33.8K ﹤0.01% 5206
2021
Q1
Sell
-300
Closed -$3K 6437
2020
Q4
$3K Sell
300
-2,500
-89% -$688K ﹤0.01% 4044
2020
Q3
$3K Sell
2,800
-2,200
-44% -$517K ﹤0.01% 3936
2020
Q2
$10K Hold
5,000
﹤0.01% 2901
2020
Q1
$155K Sell
5,000
-4,200
-46% -$657K 0.01% 1101
2019
Q4
$130K Buy
9,200
+8,700
+1,740% +$1.45M 0.01% 1057
2019
Q3
$1K Sell
500
-3,500
-88% -$465K ﹤0.01% 3885
2019
Q2
$14K Sell
4,000
-1,400
-26% -$178K ﹤0.01% 2453
2019
Q1
$54K Sell
5,400
-1,300
-19% -$175K 0.01% 1376
2018
Q4
$58K Buy
6,700
+3,500
+109% +$464K 0.01% 1377
2018
Q3
$17K Buy
3,200
+400
+14% +$67.3K ﹤0.01% 2360
2018
Q2
$49K Sell
2,800
-4,400
-61% -$785K ﹤0.01% 1625
2018
Q1
$60K Buy
7,200
+3,700
+106% +$501K 0.01% 1542
2017
Q4
$28K Buy
3,500
+2,500
+250% +$229K ﹤0.01% 2300
2017
Q3
$5K Buy
+1,000
New +$74.5K ﹤0.01% 4451

Other funds holding ONC

Cutler Group's ONC Position: Q1 2023 in Review

Cutler Group sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 714 shares — an estimated $171K sold.

Cutler Group first reported a position in ONC in Q2 2018 and held it in 11 quarters. The position peaked at $421K in Q1 2020. 219 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Cutler Group reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 714 BeOne Medicines Ltd shares in Q1 2023, an estimated $171K.
  • Cutler Group first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 11 quarters.
  • Cutler Group's BeOne Medicines Ltd position peaked at $421K in Q1 2020.
  • 219 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.